Get notified when TPST files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: TPST Tempest Therapeutics, Inc. 8-K

Tempest Therapeutics presents clinical update at ISCT 2026 Annual Meeting

Filed May 6, 2026 · Period ending May 6, 2026 · ~1 min read

Key Changes

  • medium

    Tempest issued a press release announcing a clinical update presentation at the ISCT 2026 Annual Meeting, though specific trial data or results were not disclosed in the 8-K filing itself.

  • low

    The company posted an updated corporate presentation dated May 6, 2026 to its investor relations website as a routine Regulation FD disclosure to ensure equal access to company materials.

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.

Partner

Trade TPST commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?